Suchergebnisse - (Person:"Wang, Yeming")

PubPharm (220)

81

Synthesis and biological evaluation of N 6 derivatives of 8-azapurine as novel antiplatelet agents

enthalten in: RSC medicinal chemistry | 2021

von Zhao, Z. | Wang, Y. | Tian, N. | +2

82

Procalcitonin-guided initiation of antibiotics in AECOPD inpatients : study protocol for a multicenter randomised controlled trial

enthalten in: BMJ open | 2021

von Huang, L. | Wang, J. | Gu, X. | +3

83

COMPOUND FOR INHIBITING AND INDUCING DEGRADATION OF EGFR KINASE

enthalten in: Europäisches Patentamt | 2021

von ZHAO YANPING | WANG HONGJUN | WANG YEMING | +7

84

Antibody Responses and Clinical Outcomes in Adults Hospitalized With Severe Coronavirus Disease 2019 (COVID-19) : A Post hoc Analysis of LOTUS China Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Ren, L. | Fan, G. | Wu, W. | +18

85

Long-term effects of COVID-19 on kidney function - Authors' reply

enthalten in: Lancet (London, England) | 2021

von Huang, L. | Gu, X. | Wang, Y. | +2

CommentOn: Lancet. 2021 May 15;397(10287):1806-1807. - PMID 33992141

86

The characteristics of laboratory tests at admission and the risk factors for adverse clinical outcomes of severe and critical COVID-19 patients

enthalten in: BMC infectious diseases | 2021

von Wang, L. | Cheng, X. | Dong, Q. | +12

87

The characteristics of laboratory tests at admission and the risk factors for adverse clinical outcomes of severe and critical COVID-19 patients

enthalten in: BMC infectious diseases | 2021

von Wang, L. | Cheng, X. | Dong, Q. | +12

88

Risk Factors of Viral RNAaemia and Its Association With Clinical Prognosis Among Patients With Severe COVID-19

enthalten in: Chest | 2021

von Li, H. | Gu, X. | Li, H. | +7

CommentIn: Chest. 2021 Jul;160(1):e85-e86. - PMID 34246395

89

Dynamics of the upper respiratory tract microbiota and its association with fatality in COVID-19 patients

enthalten in: ResearchSquare.com | 2021

von Li, M. | Ren, L. | Wang, Y. | +26

90

COMPOUND INHIBITING AND INDUCING DEGRADATION OF EGFR AND ALK

enthalten in: Europäisches Patentamt | 2021

von ZHAO YANPING | WANG HONGJUN | WANG YEMING | +9